Sulfated cinnamic acid oligomers as UV radiation shields for skin protection

Overview

This solution proposes sulfated 4-hydroxycinnamic acid oligomers as topical agents to shield skin from UV radiation-induced damage. These novel molecules are produced through a chemo-enzymatic synthesis process and have previously demonstrated antioxidant, anti-inflammatory, anti-elastase, and free radical scavenging activities in lung tissue, where they reversed cigarette smoke-induced emphysema in animal models. The underlying science suggests that both oligomerization and sulfation are critical to the protective function. By translating these properties to dermatological applications, the technology offers a new approach to mitigating skin damage caused by oxidation, inflammation, and free radicals generated by UV exposure.

Technical specifications

• Synthesis method: Chemo-enzymatic oligomerization of 4-hydroxycinnamic acid followed by sulfation, a scalable process previously established in published research.
• Key bioactive properties:
  • Antioxidant activity to neutralize reactive oxygen species generated by UV radiation
  • Anti-inflammatory activity to reduce cytokine-mediated skin inflammation
  • Free radical scavenging to prevent oxidative cellular damage
  • Anti-elastase activity to support tissue integrity
• Mechanism of action: Dual protection through radical scavenging and anti-cytokine effects, addressing both oxidative stress and inflammatory cascades triggered by UV exposure.
• Intended application: Topical formulation for pretreatment of skin prior to UV exposure.

Technology readiness level

The core molecules have been synthesized and characterized for structural and functional properties, including antioxidant, anti-inflammatory, and anticoagulation activities, in published preclinical studies. Validation in lung models has demonstrated efficacy in reversing cigarette smoke-induced emphysema in rats. However, dermatological validation is at an early stage. Planned future studies include in vitro UV radiation testing, skin absorption and residence time assessments, proteomic and genomic analyses of human skin responses, and receptor tyrosine kinase phosphorylation microarray studies across three different oligomer candidates. Further research or product development steps will be determined based on these forthcoming results.